Content of HLA-G+ T Cells in the Peripheral Blood from Healthy Women and Breast Cancer Patients
作者： E. O. Ostapchuk , Yu. V. Perfi l’eva , Sh. Zh. Talaeva , N. A. Omarbaeva , N. N. Belyaev
DOI: 10.1007/S10517-015-3038-Y
关键词:
摘要: The number of CD3(+)CD56-HLA-G(+) cells in the peripheral blood breast cancer patients was shown to increase by 2 times. Our results and published data suggest that relative content circulating contributes tumor development due suppression antitumor immunity.
springer.com
sci-hub.se 参考文章(9)
Gilberto Filaci, Daniela Fenoglio, Marco Fravega, Gianluca Ansaldo, Giacomo Borgonovo, Paolo Traverso, Barbara Villaggio, Alessandra Ferrera, Annalisa Kunkl, Marta Rizzi, Francesca Ferrera, Piercesare Balestra, Massimo Ghio, Paola Contini, Maurizio Setti, Daniel Olive, Bruno Azzarone, Giorgio Carmignani, Jean Louis Ravetti, Giancarlo Torre, Francesco Indiveri, CD8+CD28− T Regulatory Lymphocytes Inhibiting T Cell Proliferative and Cytotoxic Functions Infiltrate Human Cancers Journal of Immunology. ,vol. 179, pp. 4323- 4334 ,(2007) , 10.4049/JIMMUNOL.179.7.4323
Yuan Min Wang, Stephen I Alexander, CD8 regulatory T cells: what's old is now new. Immunology and Cell Biology. ,vol. 87, pp. 192- 193 ,(2009) , 10.1038/ICB.2009.8
Ute Feger, Eva Tolosa, Yu-Hwa Huang, Anne Waschbisch, Tilo Biedermann, Arthur Melms, Heinz Wiendl, HLA-G expression defines a novel regulatory T cell subset present in human peripheral blood and sites of inflammation Blood. ,vol. 110, pp. 568- 577 ,(2007) , 10.1182/BLOOD-2006-11-057125
Tomoyuki Aruga, Eiji Suzuki, Shigehira Saji, Shin-Ichirou Horiguchi, Kazumi Horiguchi, Susumu Sekine, Dai Kitagawa, Nobuaki Funata, Masakazu Toi, Kenichi Sugihara, Katsumasa Kuroi, A low number of tumor-infiltrating FOXP3-positive cells during primary systemic chemotherapy correlates with favorable anti-tumor response in patients with breast cancer Oncology Reports. ,vol. 22, pp. 273- 278 ,(2009) , 10.3892/OR_00000434
H. Wang, V. Daniel, M. Sadeghi, G. Opelz, Differences in the Induction of Induced Human CD4+ CD25+ FoxP3+ T-Regulatory Cells and CD3+ CD8+ CD28− T-Suppressor Cells Subset Phenotypes In Vitro: Comparison of Phorbol 12-Myristate 13-Acetate/Ionomycin and Phytohemagglutinin Stimulation Transplantation Proceedings. ,vol. 45, pp. 1822- 1831 ,(2013) , 10.1016/J.TRANSPROCEED.2012.10.061
Weiping Zou, Regulatory T cells, tumour immunity and immunotherapy Nature Reviews Immunology. ,vol. 6, pp. 295- 307 ,(2006) , 10.1038/NRI1806
Eberhard Gunsilius, Beatrix Grubeck-Loebenstein, Dominik Wolf, Anna Maria Wolf, Michael Steurer, Guenther Gastl, Increase of regulatory T cells in the peripheral blood of cancer patients. Clinical Cancer Research. ,vol. 9, pp. 606- 612 ,(2003)
Sylvain Ladoire, Laurent Arnould, Lionel Apetoh, Bruno Coudert, Francois Martin, Bruno Chauffert, Pierre Fumoleau, François Ghiringhelli, Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating foxp3+ regulatory T cells. Clinical Cancer Research. ,vol. 14, pp. 2413- 2420 ,(2008) , 10.1158/1078-0432.CCR-07-4491
Yu-Hwa Huang, Alla L. Zozulya, Christian Weidenfeller, Nicholas Schwab, Heinz Wiendl, T cell suppression by naturally occurring HLA-G-expressing regulatory CD4+ T cells is IL-10-dependent and reversible Journal of Leukocyte Biology. ,vol. 86, pp. 273- 281 ,(2009) , 10.1189/JLB.1008649